Express Scripts Says Class Action's Recall Bid Hits FDA Turf

Law360, New York (March 5, 2013, 4:58 PM EST) -- Pharmacy benefit manager Express Scripts Inc. on Monday asked a New Jersey federal judge to dispense with a proposed consumer class action seeking a wider recall of glass-tainted pills made by Ranbaxy Laboratories Ltd., saying the court has no authority to intrude on regulators’ turf.

In its motion to dismiss, Express Scripts attacked the lawsuit as an affront to the expertise of the U.S. Food and Drug Administration, which has said there is an “extremely low” risk of health problems associated with Ranbaxy’s generic version of...
To view the full article, register now.